These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30484950)

  • 21. The DEAD-box RNA helicase DDX5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer.
    Tabassum S; Basu M; Ghosh MK
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194933. PubMed ID: 36997114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
    J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SETD5 regulates the OGT-catalyzed O-GlcNAcylation of RNA polymerase II, which is involved in the stemness of colorectal cancer cells.
    Cho HI; Jo S; Kim MS; Kim HB; Liu X; Xuan Y; Cho JW; Jang YK
    Sci Rep; 2023 Nov; 13(1):19885. PubMed ID: 37963940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
    Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of p68 RNA Helicase (DDX5) Activates a Survival Pathway Involving mTOR and MDM2 Signals.
    Kokolo M; Bach-Elias M
    Folia Biol (Praha); 2017; 63(2):52-59. PubMed ID: 28557706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
    Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
    Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SAV1 represses the development of human colorectal cancer by regulating the Akt-mTOR pathway in a YAP-dependent manner.
    Jiang J; Chang W; Fu Y; Gao Y; Zhao C; Zhang X; Zhang S
    Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28618450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.
    Wang D; Huang J; Hu Z
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.011932. PubMed ID: 22086602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
    Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
    J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
    Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
    Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F
    Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
    Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
    Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.
    Ishimura E; Nakagawa T; Moriwaki K; Hirano S; Matsumori Y; Asahi M
    Cancer Sci; 2017 Dec; 108(12):2373-2382. PubMed ID: 28973823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway.
    Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.
    Olivier-Van Stichelen S; Dehennaut V; Buzy A; Zachayus JL; Guinez C; Mir AM; El Yazidi-Belkoura I; Copin MC; Boureme D; Loyaux D; Ferrara P; Lefebvre T
    FASEB J; 2014 Aug; 28(8):3325-38. PubMed ID: 24744147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
    Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Sekine H; Okazaki K; Kato K; Alam MM; Shima H; Katsuoka F; Tsujita T; Suzuki N; Kobayashi A; Igarashi K; Yamamoto M; Motohashi H
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29941490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.